Flagship, Pfizer team up in deal worth up to $7 billion
The new Pfizer partnership with Flagship will fund the development of up to 10 drug candidates.
Related Articles
We are all complicit in the big lie of health insurance
“Insurers deliver the deception we seek — by promising to pay for ‘medically necessary’ care and telling us nothing about whether and how they weigh…
Trump’s pick for science adviser is a rarity among his nominees — he’s not controversial
Unlike most previous OSTP directors, Michael Kratsios is not an esteemed scientist or engineer, but he has earned mostly positive reviews.
A new Ebola Sudan vaccine trial is underway
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning! Did you know it’s
A crucial moment for RFK Jr. And for Bill Cassidy
This week in health care politics and policy: RFK Jr. faces a key test, and Dr. Oz’s rise to a top Trump role.
He ruled the operating room and then daytime TV. Now, Dr. Oz is set to take over a $1.5 trillion health agency
Dr. Oz, the surgeon turned daytime TV host, has a large contingent of loyal supporters who back his nomination to oversee Medicare and Medicaid.
Senate Republicans advance RFK Jr.’s confirmation and warn him on vaccines
Kennedy nomination clears major hurdle as GOP senators appear to draw a red line on vaccines and say they’ll keep a close eye on RFK…
NIH resumes grant reviews after two-week pause, along with some communications and travel
National Institutes of Health holds first grant review meetings since first days of the Trump administration
Study of Amgen’s early obesity candidate paused by FDA
The company said the agency’s hold was “not related to the drug,” dubbed AMG 513, and that discussions were underway to reopen the study.
Pharmalittle: We’re reading about pharma donations to lawmakers, PBM transparency in New York, and more
In today’s Pharmalittle roundup: pharma donations to lawmakers, PBM transparency in New York, and more.
International monitor allows monkey shipments from Cambodia to continue
International officials voted to defer a recommendation to suspend shipments of long-tailed macaques used for biomedical research from Cambodia.